IN2014MN02127A - - Google Patents
Info
- Publication number
- IN2014MN02127A IN2014MN02127A IN2127MUN2014A IN2014MN02127A IN 2014MN02127 A IN2014MN02127 A IN 2014MN02127A IN 2127MUN2014 A IN2127MUN2014 A IN 2127MUN2014A IN 2014MN02127 A IN2014MN02127 A IN 2014MN02127A
- Authority
- IN
- India
- Prior art keywords
- compounds
- calcium
- crac
- channel
- formula
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 abstract 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract 2
- 150000001669 calcium Chemical class 0.000 abstract 2
- 229910052791 calcium Inorganic materials 0.000 abstract 2
- 239000011575 calcium Substances 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 208000011580 syndromic disease Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN2127MUN2014 IN2014MN02127A (ro) | 2012-05-02 | 2013-05-01 |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN6KO2012 | 2012-05-02 | ||
| IN1474KO2012 | 2012-12-28 | ||
| PCT/IB2013/053446 WO2013164773A1 (en) | 2012-05-02 | 2013-05-01 | Substituted pyrazole compounds as crac modulators |
| IN2127MUN2014 IN2014MN02127A (ro) | 2012-05-02 | 2013-05-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014MN02127A true IN2014MN02127A (ro) | 2015-09-11 |
Family
ID=48428566
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN2127MUN2014 IN2014MN02127A (ro) | 2012-05-02 | 2013-05-01 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US9409898B2 (ro) |
| EP (1) | EP2844656A1 (ro) |
| AU (1) | AU2013255441B2 (ro) |
| CA (1) | CA2871222A1 (ro) |
| IN (1) | IN2014MN02127A (ro) |
| WO (1) | WO2013164773A1 (ro) |
| ZA (1) | ZA201407668B (ro) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015197188A1 (en) * | 2014-06-24 | 2015-12-30 | Grünenthal GmbH | Pyrazolyl-based carboxamides as crac inhibitors |
| WO2015197187A1 (en) * | 2014-06-24 | 2015-12-30 | Grünenthal GmbH | Pyrazolyl-based carboxamides v |
| CN107847548B (zh) | 2015-05-18 | 2022-06-14 | 贝思以色列女会吏医学中心公司 | P物质、肥大细胞脱颗粒抑制剂和周围神经病 |
| KR20210062023A (ko) | 2018-09-14 | 2021-05-28 | 리젠 파마슈티컬스 아게 | Crac 억제제 및 코르티코스테로이드를 포함하는 조성물 및 그의 사용 방법 |
| US11034669B2 (en) | 2018-11-30 | 2021-06-15 | Nuvation Bio Inc. | Pyrrole and pyrazole compounds and methods of use thereof |
| MX2021014864A (es) | 2019-06-06 | 2022-01-18 | Basf Se | N-(pirid-3-il)carboxamidas fungicidas. |
| CN110604735B (zh) * | 2019-09-18 | 2022-10-25 | 华东师范大学 | 一种治疗肝纤维化、硬皮病的化合物及其应用 |
| WO2021063735A1 (en) | 2019-10-02 | 2021-04-08 | Basf Se | New bicyclic pyridine derivatives |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU751139B2 (en) * | 1997-10-13 | 2002-08-08 | Astellas Pharma Inc. | Amide derivative |
| EP1068187A1 (en) * | 1998-04-08 | 2001-01-17 | Abbott Laboratories | Pyrazole inhibitors of cytokine production |
| US6506747B1 (en) * | 1998-06-05 | 2003-01-14 | Boehringer Ingelheim Pharmaceuticals, Inc. | Substituted 1-(4-aminophenyl)pyrazoles and their use as anti-inflammatory agents |
| PT1651232E (pt) | 2003-07-23 | 2011-02-16 | Synta Pharmaceuticals Corp | Compostos para inflamação e utilizações imunorelacionadas |
| MX2007003342A (es) | 2004-09-21 | 2007-06-05 | Synta Pharmaceutical Corp | Compuestos para inflamacion y usos relacionados con trastornos inmunitarios. |
| TWI441819B (zh) | 2005-01-07 | 2014-06-21 | Synta Pharmaceuticals Corp | 用於炎症及免疫相關用途之化合物 |
| CN101163478B (zh) | 2005-01-25 | 2013-11-27 | 幸讬制药公司 | 用于炎症及免疫相关用途之化合物 |
| TWI444187B (zh) | 2005-01-25 | 2014-07-11 | Synta Pharmaceuticals Corp | 用於炎症及免疫相關用途之噻吩化合物 |
| JP5430943B2 (ja) | 2006-01-25 | 2014-03-05 | シンタ ファーマシューティカルズ コーポレーション | 炎症及び免疫関連用途のための置換芳香族化合物 |
| US20070275960A1 (en) | 2006-01-25 | 2007-11-29 | Synta Pharmaceuticals Corp. | Phenyl and pyridyl compounds for inflammation and immune-related uses |
| US8623871B2 (en) | 2006-01-25 | 2014-01-07 | Synta Pharmaceuticals Corp. | Substituted biaryl compounds for inflammation and immune-related uses |
| US20070254926A1 (en) | 2006-01-31 | 2007-11-01 | Jun Jiang | Pyridylphenyl compounds for inflammation and immune-related uses |
| JP5431323B2 (ja) | 2007-08-01 | 2014-03-05 | シンタ ファーマシューティカルズ コーポレーション | 炎症および免疫関連用途のためのピリジン化合物 |
| CA2699157A1 (en) | 2007-09-10 | 2009-03-19 | Calcimedica, Inc. | Compounds that modulate intracellular calcium |
| WO2009076454A2 (en) | 2007-12-12 | 2009-06-18 | Calcimedica, Inc. | Compounds that modulate intracellular calcium |
| EP2321303B1 (en) | 2008-08-27 | 2019-11-27 | Calcimedica, Inc. | Compounds that modulate intracellular calcium |
| US8524763B2 (en) | 2008-09-22 | 2013-09-03 | Calcimedica, Inc. | Inhibitors of store operated calcium release |
| EP2350006A1 (en) | 2008-10-01 | 2011-08-03 | Synta Pharmaceuticals Corp. | Compounds for inflammation and immune-related uses |
| EP2477982A4 (en) | 2009-09-16 | 2013-04-03 | Calcimedica Inc | COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM |
| US8377970B2 (en) | 2009-10-08 | 2013-02-19 | Rhizen Pharmaceuticals Sa | Modulators of calcium release-activated calcium channel |
| US20120046301A1 (en) | 2010-08-20 | 2012-02-23 | Gruenenthal Gmbh | Substituted Cyclic Carboxamide and Urea Derivatives as Ligands of the Vanilloid Receptor |
| JP5387541B2 (ja) | 2010-10-29 | 2014-01-15 | 住友電装株式会社 | グロメット |
| EP2632906B1 (en) * | 2010-10-30 | 2016-04-06 | Lupin Limited | Oxazoline and isoxazoline derivatives as crac modulators |
| AU2011328520A1 (en) | 2010-11-10 | 2013-05-02 | Grunenthal Gmbh | Substituted heteroaromatic carboxamide and urea derivatives as vanilloid receptor ligands |
| JP5985611B2 (ja) | 2011-05-03 | 2016-09-06 | シンタ ファーマシューティカルズ コーポレーション | 炎症および免疫関連用途のための化合物 |
| WO2013059677A1 (en) | 2011-10-19 | 2013-04-25 | Calcimedica, Inc. | Compounds that modulate intracellular calcium |
| US20140256771A1 (en) | 2011-10-19 | 2014-09-11 | Calcimedica, Inc. | Compounds that modulate intracellular calcium |
-
2013
- 2013-05-01 IN IN2127MUN2014 patent/IN2014MN02127A/en unknown
- 2013-05-01 CA CA 2871222 patent/CA2871222A1/en not_active Abandoned
- 2013-05-01 EP EP13722112.3A patent/EP2844656A1/en not_active Withdrawn
- 2013-05-01 AU AU2013255441A patent/AU2013255441B2/en not_active Expired - Fee Related
- 2013-05-01 US US14/398,161 patent/US9409898B2/en not_active Expired - Fee Related
- 2013-05-01 WO PCT/IB2013/053446 patent/WO2013164773A1/en not_active Ceased
-
2014
- 2014-10-22 ZA ZA2014/07668A patent/ZA201407668B/en unknown
-
2016
- 2016-06-28 US US15/194,795 patent/US20160304507A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2013164773A1 (en) | 2013-11-07 |
| CA2871222A1 (en) | 2013-11-07 |
| AU2013255441A1 (en) | 2014-11-13 |
| US20150111925A1 (en) | 2015-04-23 |
| US20160304507A1 (en) | 2016-10-20 |
| ZA201407668B (en) | 2015-11-25 |
| AU2013255441B2 (en) | 2017-11-09 |
| US9409898B2 (en) | 2016-08-09 |
| EP2844656A1 (en) | 2015-03-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2014MN02126A (ro) | ||
| IN2014MN02127A (ro) | ||
| CO6430427A2 (es) | Derivados de benzofuranilo | |
| TN2013000348A1 (en) | Compounds and compositions as trk inhibitors | |
| MX2013012896A (es) | Compuestos novedosos como moduladores de proteina cinasas. | |
| GEP20166438B (en) | Imidazopyrrolidinone compounds | |
| PH12015500551A1 (en) | Tricyclic quinoline and quinoline derivatives | |
| CR20110103A (es) | Heteroarilos sustituidos | |
| IN2014CN04907A (ro) | ||
| MD20140109A2 (ro) | Compuşi ai indolului şi indazolului care activează AMPK | |
| PH12014502757B1 (en) | Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases | |
| MX367420B (es) | Metodos y composiciones para inhibicion de proteinas que contienen bromodominio. | |
| WO2012170931A3 (en) | Compounds that modulate intracellular calcium | |
| IN2012DN00943A (ro) | ||
| MX2015012867A (es) | Compuestos aromaticos multisustituidos como inhibidores de serina proteasa. | |
| MX337711B (es) | Compuestos que modulan el calcio intracelular. | |
| TN2013000346A1 (en) | Asymmetric ureas and medical uses thereof | |
| PH12013500831A1 (en) | Oxazoline and isoxazoline derivatives as crac modulators | |
| PH12014501979A1 (en) | Fused bicyclic 2,4-diaminopyrimidine derivative as a dual alk and fak inhibitor | |
| AU2011322715A8 (en) | Treatment of MeCP2-associated disorders | |
| PH12014501891B1 (en) | Substituted chroman compounds as calcium sensing receptor modulators | |
| UY36081A (es) | Compuestos inhibidores de metaloenzima como fungicidas. | |
| WO2012170951A3 (en) | Compounds that modulate intracellular calcium | |
| TW201613878A (en) | Pyrazine GPR40 agonists for the treatment of type II diabetes | |
| HK1220699A1 (zh) | 治疗神经退行性蛋白质病的化合物 |